Navigation Links
Human Genome Sciences Announces Third Quarter 2007 Financial Results and Key Developments
Date:11/1/2007

combination with ribavirin. ACHIEVE 2/3 enrolled 933 treatment-naive patients with genotypes 2 and 3 chronic hepatitis C. ACHIEVE 1, the first of the two global Phase 3 trials, completed enrollment of 1331 treatment-naive patients with genotype 1 chronic hepatitis C in August 2007. The Company originally projected completing enrollment of the Phase 3 trials by the end of 2007. HGS expects to have all Phase 3 data available by spring 2009 to support the filing of global marketing authorization applications by fall 2009. Albuferon is being developed by HGS and Novartis under an exclusive worldwide co- development and commercialization agreement entered into in June 2006. HGS received a $40 million milestone payment from Novartis in the third quarter of 2007 for the successful completion of a Phase 2b trial of Albuferon in treatment-naive patients with chronic hepatitis C.

Albuferon requires half as many injections as Pegasys (peginterferon alfa- 2a), the current market leader, and Phase 2 clinical results suggest that Albuferon may offer efficacy at least comparable to Pegasys, with comparable safety and the potential for less impairment of quality of life and daily activity during treatment. HGS believes that Albuferon could become the interferon of choice for the treatment of hepatitis C.

The final results of Phase 2 trials of Albuferon will be presented at the annual meeting of the American Association for the Study of Liver Disease in Boston, November 2-6, 2007.

LymphoStat-B: Enrollment of Phase 3 Trials Progressing

Enrollment of both pivotal Phase 3 trials of LymphoStat-B (belimumab) in patients with active systemic lupus erythematosus (SLE) is progressing. HGS expects to complete enrollment as previously indicated in 2008. LymphoStat-B is being developed by HGS and GSK under a definitive co-development and commercialization agreement entered into in August 2006.

Based on Phase 2 clinical results, HGS believes that LymphoStat-B could
'/>"/>

SOURCE Human Genome Sciences, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related biology technology :

1. Human Primary Preadipocytes and Differentiated Adipocytes
2. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
3. Control RT-PCR Primers for Human Gene Transcripts with Varying Abundance
4. New Mammalian Expression Vectors Employ Stable, High-Level Fluorescence Humanized Renilla GFP Reporter
5. Human Universal cDNA Library Array I
6. Map and Link Human Genetic Disorders with SSLP Analysis
7. RT-PCR Primer Sets for Human and Mouse Mismatch Repair Genes
8. Transfection of Green Fluorescent Protein into Human Adrenalcarcinoma Cells
9. Fluorescence-Based Single-Tube Assays to Rapidly Detect Human Gene Mutations
10. Improve Lipid- or Calcium Phosphate-Mediated Transfection of Human Dermal Fibroblasts
11. Sequence-Validated and Expression-Tested Human cDNA in a Dual Expression Vector
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/29/2015)... Asia-Pacific / Japan (Q2 2015: +14% CER ... 2015 on high-single-digit growth in China , as well as ... . Europe / Middle East ... of sales) showed gains in Germany , Turkey ... 2015: +4% CER / 49% of sales) grew 11%, excluding U.S. HPV sales, ...
(Date:7/29/2015)... July 29, 2015  AsureQuality and Ubiquitome have ... for applications in food and primary production sectors. ... real-time PCR device, the Freedom4. AsureQuality ... to the supermarket shelf for producers, processors and ... in animal disease control and pest management and ...
(Date:7/29/2015)... ... July 29, 2015 , ... ... its GHS Label Guide . To align chemical container labeling with OSHA’s ... includes explanations of label components, an example of an accurate label, and pictogram ...
(Date:7/29/2015)... , July 29, 2015  Pfenex Inc. (NYSE ... financial results will be released on Thursday, August 13, ... Eastern Time, Pfenex management will host a conference call ... update.  A press release outlining the financial results and ... call. Please call 1-866-376-8058 (US) or 1-412-542-4131 ...
Breaking Biology Technology:QIAGEN Reports Results for Second Quarter and First Half of 2015 2QIAGEN Reports Results for Second Quarter and First Half of 2015 3QIAGEN Reports Results for Second Quarter and First Half of 2015 4QIAGEN Reports Results for Second Quarter and First Half of 2015 5QIAGEN Reports Results for Second Quarter and First Half of 2015 6QIAGEN Reports Results for Second Quarter and First Half of 2015 7QIAGEN Reports Results for Second Quarter and First Half of 2015 8QIAGEN Reports Results for Second Quarter and First Half of 2015 9QIAGEN Reports Results for Second Quarter and First Half of 2015 10AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2Brady Announces a New GHS Label Guide 2Pfenex To Report Second Quarter 2015 Results and Provide Business Update on Thursday, August 13, 2015 2
... Md., March 8, 2011 -- The Maryland Technology Enterprise ... for the University of Maryland $75K Business Plan ... has served as a launch pad for Inc. ... 71 entries in the categories of high-technology and biotechnology ...
... OMAHA, Neb., March 8, 2011 Transgenomic, Inc. ... announced the following Webcast:What: , Transgenomic, Inc. Fourth Quarter ... Friday, March 11, 2011 @ 11:00 a.m. EasternWhere: , ... Simply log on to the web at the address ...
... ORINDA, Calif., March 8, 2011 Management teams ... scale-up and manufacturing of biologics (biopharmaceuticals, vaccines, biotherapeutics ... Facilities 2011 Conference Aug. 8-9 ... best-in-class industry solutions. The conference ...
Cached Biology Technology:Mtech Announces Semifinalists for University of Maryland $75K Business Plan Competition 2Mtech Announces Semifinalists for University of Maryland $75K Business Plan Competition 3Mtech Announces Semifinalists for University of Maryland $75K Business Plan Competition 4Mtech Announces Semifinalists for University of Maryland $75K Business Plan Competition 5Mtech Announces Semifinalists for University of Maryland $75K Business Plan Competition 6Transgenomic to Hold Fourth Quarter Financial Results Conference Call on March 11, 2011 2Bioprocessing Facilities 2011 Conference to be held Aug. 8-9 in San Diego 2
(Date:7/8/2015)... , N.J. and NEW YORK , ... and Guidepoint today announced BD & ... healthcare companies with free access to Guidepoint,s expert network ... start-ups that are developing cutting-edge technologies to improve healthcare ... dedicated Guidepoint research manager, each start-up entrepreneur will be ...
(Date:7/7/2015)... , July 7, 2015  Based on its ... & Sullivan recognizes Credence ID, LLC with the ... Company of the Year Award. Credence ID has ... in its mission of offering enrollment and identification ... As Credence ID was formed by experts from ...
(Date:7/2/2015)... GOTHENBURG, Sweden , July 2, 2015 ... fingerprint sensors FPC1025, FPC1035, FPC1145 and FPC1155 from the distributor ... is one of FPC,s distributors in Asia ... Q4 2015. The sensors will be used by smartphone manufacturers ... 268 MSEK is included in the communicated revenue guidance of ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5FPC Receives Order for Touch Fingerprint Sensors of 268 MSEK 2
... scientist and designer from Africa have together created a ... insecticides for warding off mosquitoes infected with malaria, a ... continent. Though insecticide-treated nets are commonly used to ... garment can be worn throughout the day to provide ...
... WHO: American Association of Pharmaceutical Scientists (AAPS) ... (NBC) will gather scientists from industry, government, and ... geared toward the biotechnology sector of the pharmaceutical ... new advanced Immunogenicity Training Course and two AAPS ...
... Institute, which has been developing innovative low-cost batteries that ... and high energy densities, announced that it has built ... said large-scale commercialization of the battery would start later ... friendlier and less costly alternative to nickel cadmium batteries. ...
Cached Biology News:African scientist, designer partner to fashion anti-malaria garment that wards off bugs 2CUNY Energy Institute battery system could reduce buildings' electric bills 2
HOXC11 Antibody...
Anti-MMP-19 (RASI), carboxy terminal region; rabbit host...
Rabbit polyclonal to MAP3K12 ( Abpromise for all tested applications). Antigen: Synthetic peptide conjugated to KLH from the C-terminal region of human MAP3K12 Entrez Gene ID: 7786 Swiss ...
Phosphatidylinositol transfer protein beta isoform (PtdIns transfer protein beta) (PtdInsTP) (PI-TP-beta). [Source:Uniprot/SWISSPROT;Acc:P48739] Antigen: Recombinant Protein Epitope Signature Tag...
Biology Products: